|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
ESMO Guidelines Working Group; Van Cutsem
EJD. Advanced colorectal cancer: ESMO clinical recommendations for
diagnosis, treatment and follow-up. Ann Oncol. 18 (Suppl
2):ii25–ii26. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kow AWC: Hepatic metastasis from
colorectal cancer. J Gastrointest Oncol. 10:1274–1298.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Muller MF, Ibrahim AE and Arends MJ:
Molecular pathological classification of colorectal cancer.
Virchows Arch. 469:125–134. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Piawah S and Venook AP: Targeted therapy
for colorectal cancer metastases: A review of current methods of
molecularly targeted therapy and the use of tumor biomarkers in the
treatment of metastatic colorectal cancer. Cancer. 125:4139–4147.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gui Z, Ying X and Liu C: NXPH4 Used as a
new prognostic and immunotherapeutic marker for muscle-invasive
bladder cancer. J Oncol. 2022(4271409)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tang Q, Chen YM, Shen MM, Dai W, Liang H,
Liu JN and Gao J: Increased expression of NXPH4 correlates with
immune cell infiltration and unfavorable prognosis in
hepatocellular carcinoma. J Oncol. 2022(5005747)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhou L, Rueda M and Alkhateeb A:
Classification of breast cancer Nottingham prognostic index using
high-dimensional embedding and residual neural network. Cancers
(Basel). 14(934)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yang Z, Wei B, Qiao A, Yang P, Chen W,
Zhen D and Qiu X: A novel EZH2/NXPH4/CDKN2A axis is involved in
regulating the proliferation and migration of non-small cell lung
cancer cells. Biosci Biotechnol Biochem. 86:340–350.
2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42 (Database issue):D92–D47. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lanczky A and Gyorffy B: Web-based
survival analysis tool tailored for medical research (KMplot):
Development and implementation. J Med Internet Res.
23(e27633)2021.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Fornes O, Castro-Mondragon JA, Khan A, van
der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M,
Baranašić D, et al: JASPAR 2020: Update of the open-access database
of transcription factor binding profiles. Nucleic Acids Res.
48:D87–D92. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Stiksma J, Grootendorst DC and van der
Linden PW: CA 19-9 as a marker in addition to CEA to monitor
colorectal cancer. Clin Colorectal Cancer. 13:239–244.
2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li J, Ma X, Chakravarti D, Shalapour S and
DePinho RA: Genetic and biological hallmarks of colorectal cancer.
Genes Dev. 35:787–820. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lech G, Słotwiński R, Słodkowski M and
Krasnodębski IW: Colorectal cancer tumour markers and biomarkers:
Recent therapeutic advances. World J Gastroenterol. 22:1745–1755.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Eun JW, Jang JW, Yang HD, Kim J, Kim SY,
Na MJ, Shin E, Ha JW, Jeon S, Ahn YM, et al: Serum proteins, HMMR,
NXPH4, PITX1 and THBS4; a panel of biomarkers for early diagnosis
of hepatocellular carcinoma. J Clin Med. 11(2128)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang D, Zhang P, Liu Z, Xing' Y and Xiao
Y: NXPH4 promotes gemcitabine resistance in bladder cancer by
enhancing reactive oxygen species and glycolysis activation through
modulating NDUFA4L2. Cancers (Basel). 14(3782)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu J, Zhang J, Wang Z, Xi Y, Bai L and
Zhang Y: Knockdown of circAPLP2 inhibits progression of colorectal
cancer by regulating miR-485-5p/FOXK1 axis. Cancer Biother
Radiopharm. 36:737–752. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Han Y, Peng Y, Liu S, Wang X, Cai C, Guo
C, Chen Y, Gao L, Huang Q, He M, et al: tRF3008A suppresses the
progression and metastasis of colorectal cancer by destabilizing
FOXK1 in an AGO-dependent manner. J Exp Clin Cancer Res.
41(32)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wu M, Wang J, Tang W, Zhan X, Li Y, Peng
Y, Huang X, Bai Y, Zhao J, Li A, et al: FOXK1 interaction with FHL2
promotes proliferation, invasion and metastasis in colorectal
cancer. Oncogenesis. 5(e271)2016.PubMed/NCBI View Article : Google Scholar
|
